Evidence of epigenetic oncogenesis: a turning point in cancer research

Jean-Pascal Capp,Benoît Aliaga,Vera Pancaldi

2024-11-21

Abstract:In cancer research, the term epigenetics was used in the 1970s in its modern sense encompassing non-genetic events modifying the chromatin state, mainly to oppose the emerging oncogene paradigm. However, starting from the establishment of this prominent concept, the importance of these epigenetic phenomena in cancer rarely led to questioning the causal role of genetic alterations. Only in the last 10 years, the accumulation of problematic data, better experimental technologies, and some ambitious models pushed the idea that epigenetics could be at least as important as genetics in early oncogenesis. Until this year, a direct demonstration of epigenetic oncogenesis was still lacking. Now Parreno, Cavalli and colleagues, using a refined experimental model in the fruit fly Drosophila melanogaster, enforced the initiation of tumours solely by imposing a transient loss of Polycomb repression, leading to a purely epigenetic oncogenesis phenomenon. Despite a few caveats that we discuss, this pioneering work represents a major breakpoint in cancer research that leads us to consider the theoretical and conceptual implications on oncogenesis and to search for links between this artificial experimental model and naturally occurring processes, while revisiting cancer theories that were previously proposed as alternatives to the oncogene-centered paradigm.

Genomics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **In cancer research, can it be proven that epigenetic changes themselves can be the initial and primary cause of carcinogenesis without relying on gene mutations?**

Specifically, this paper discusses the following points:

1. **Historical Background and Traditional Views**:
- Traditional cancer research has mainly focused on gene mutations (such as mutations in oncogenes and tumor - suppressor genes) as the initial cause of cancer.
- Epigenetic changes (such as DNA methylation, histone modification, etc.) are usually considered secondary or the result of gene mutations.

2. **Presentation of New Evidence**:
- In recent years, more and more studies have shown that epigenetic changes may play a key role in the early carcinogenesis process.
- In particular, the experiments by Parreno et al. in the Drosophila melanogaster model directly proved for the first time that only through transient Polycomb repression (an epigenetic regulatory mechanism), tumorigenesis can be triggered. This indicates that epigenetic changes themselves can be the main cause of carcinogenesis.

3. **Impact on Theories and Concepts**:
- This finding challenges the traditional gene - mutation - centered carcinogenesis theory and proposes that epigenetic changes may be one of the key factors in cancer occurrence.
- The paper also explores the impact of this finding on existing cancer theories, especially those alternative theories that attempt to explain cancer occurrence, such as the Tissue Organization Field Theory (TOFT) and other theories that emphasize the importance of the microenvironment and inter - cellular communication.

4. **Directions for Future Research**:
- Future research needs to further verify whether these epigenetic changes can cause cancer in mammals (including humans).
- It is necessary to explore the specific mechanisms that lead to epigenetic changes such as Polycomb repression, and how these changes interact with environmental factors (such as inflammation, metabolic changes, etc.).

In summary, this paper aims to explore and provide evidence to support the possibility that epigenetic changes are the initial and main cause of cancer occurrence, and promote the transformation of cancer research from the traditional gene - mutation - centered paradigm to a more comprehensive perspective.